Thomas John Charles
- SEC CIK
- 0002114900
In the past year, 2 open-market sale filings worth $541.2K and no purchases.
Current role at each company
- KRYS Krystal Biotech, Inc.EVP, General Counselas of Jun 26, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- $541.2K
- 2 filings
- Net
- −$541.2K
- Bought minus sold
- Companies
- 1
- With open-market trades
Trades
Every Form 4 that lists Thomas John Charles as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Jun 26, 2026 (view filing) | Jun 25 | 1 day | Thomas John CharlesEVP, General Counsel | SSale | −1.00K | $347.27 | −$347.3K | −100.0%0 after | 10b5-1 |
| May 27, 2026 (view filing) | May 26 | 1 day | Thomas John CharlesEVP, General Counsel | SSale | −642 | $302.03 | −$193.9K | −100.0%0 after | 10b5-1 |